Published in Stroke on February 01, 2007
Post-stroke Immunological Changes in Younger Stroke Patients | NCT03725137
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol (2009) 2.98
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One (2008) 2.39
Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience (2008) 2.01
The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation (2010) 1.54
Recombinant T cell receptor ligand treats experimental stroke. Stroke (2009) 1.33
CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab Brain Dis (2010) 1.33
Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J Immunol (2010) 1.25
Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab (2012) 1.22
Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab (2010) 1.19
Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp Transl Stroke Med (2009) 1.15
Attenuated inflammatory response in aged mice brains following stroke. PLoS One (2011) 1.14
DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci (2015) 1.12
Acute Thrombocytopenia, Leucopenia, and Multiorgan Dysfunction: The First Case of SFTS Bunyavirus outside China? Case Rep Infect Dis (2011) 1.10
A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Transl Stroke Res (2012) 1.10
Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab Brain Dis (2011) 1.09
Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol (2013) 1.09
Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses. J Cereb Blood Flow Metab (2010) 1.08
Models of autoimmune demyelination in the central nervous system: on the way to translational medicine. Exp Transl Stroke Med (2009) 1.03
Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp Neurol (2013) 1.03
Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression. Stem Cells Transl Med (2015) 1.02
CNS leptin action modulates immune response and survival in sepsis. J Neurosci (2010) 1.01
Infection after acute ischemic stroke: risk factors, biomarkers, and outcome. Stroke Res Treat (2011) 1.01
Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity. Metab Brain Dis (2011) 0.99
Simvastatin attenuates stroke-induced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice. Stroke (2013) 0.99
Role of CCR2 in inflammatory conditions of the central nervous system. J Cereb Blood Flow Metab (2014) 0.97
Infection after intracerebral hemorrhage: risk factors and association with outcomes in the ethnic/racial variations of intracerebral hemorrhage study. Stroke (2014) 0.95
Sensitization and tolerization to brain antigens in stroke. Neuroscience (2008) 0.93
Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke. Transl Stroke Res (2014) 0.92
Autonomic nervous system and immune system interactions. Compr Physiol (2014) 0.92
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background. Neural Plast (2015) 0.91
Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke. Transl Stroke Res (2014) 0.91
Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke. J Neuroinflammation (2011) 0.91
Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun (2014) 0.88
Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia. Ann Neurol (2014) 0.88
Surgical manipulation compromises leukocyte mobilization responses and inflammation after experimental cerebral ischemia in mice. Front Neurosci (2014) 0.86
Antigen-specific immune reactions to ischemic stroke. Front Cell Neurosci (2014) 0.86
Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients. PLoS One (2013) 0.85
Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach. J Cereb Blood Flow Metab (2013) 0.84
Role of dihydrotestosterone in post-stroke peripheral immunosuppression after cerebral ischemia. Brain Behav Immun (2011) 0.84
Risk assessment of ischemic stroke associated pneumonia. World J Emerg Med (2014) 0.84
miRNA functional synergistic network analysis of mice with ischemic stroke. Neurol Sci (2014) 0.83
Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective. J Aging Res (2011) 0.83
Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PLoS One (2013) 0.82
Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke. J Cereb Blood Flow Metab (2015) 0.82
Immune effects of mesenchymal stromal cells in experimental stroke. J Cereb Blood Flow Metab (2012) 0.82
Hospital acquired pneumonia is linked to right hemispheric peri-insular stroke. PLoS One (2013) 0.81
Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun (2016) 0.80
Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy. PLoS One (2016) 0.80
Sex differences and the role of IL-10 in ischemic stroke recovery. Biol Sex Differ (2015) 0.79
Lymphopenia, Infectious Complications, and Outcome in Spontaneous Intracerebral Hemorrhage. Neurocrit Care (2016) 0.79
Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice. Neuroscience (2014) 0.79
Cytotoxic function of CD8+ T lymphocytes isolated from patients with acute severe cerebral infarction: an assessment of stroke-induced immunosuppression. BMC Immunol (2013) 0.79
DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury. Transl Stroke Res (2016) 0.78
The battle of the sexes for stroke therapy: female- versus male-derived stem cells. CNS Neurol Disord Drug Targets (2013) 0.78
Correlation between inflammatory factors and post-stroke pneumonia in diabetic patients. Exp Ther Med (2013) 0.78
Recurrent mild cerebral ischemia: enhanced brain injury following acute compared to subacute recurrence in the rat. BMC Neurosci (2016) 0.78
Adult stem cell transplantation: is gender a factor in stemness? Int J Mol Sci (2014) 0.78
Catecholamines, steroids and immune alterations in ischemic stroke and other acute diseases. Aging Dis (2014) 0.78
Autoimmune responses to brain following stroke. Transl Stroke Res (2012) 0.78
Androgens and stroke: good, bad or indifferent? Exp Neurol (2014) 0.78
Depletion of Cultivatable Gut Microbiota by Broad-Spectrum Antibiotic Pretreatment Worsens Outcome After Murine Stroke. Stroke (2016) 0.78
A novel SPECT-based approach reveals early mechanisms of central and peripheral inflammation after cerebral ischemia. J Cereb Blood Flow Metab (2015) 0.77
The Role of Monocytes in Ischemic Stroke Pathobiology: New Avenues to Explore. Front Aging Neurosci (2016) 0.77
Septic encephalopathy: when cytokines interact with acetylcholine in the brain. Mil Med Res (2014) 0.77
Dynamic Modulation of Microglia/Macrophage Polarization by miR-124 after Focal Cerebral Ischemia. J Neuroimmune Pharmacol (2016) 0.77
Amelioration of experimental arthritis by stroke-induced immunosuppression is independent of Treg cell function. Ann Rheum Dis (2013) 0.77
Circulating T cell subsets are altered in individuals with chronic spinal cord injury. Immunol Res (2015) 0.77
Study protocol: prediction of stroke associated infections by markers of autonomic control. BMC Neurol (2014) 0.76
Brain-lung crosstalk: Implications for neurocritical care patients. World J Crit Care Med (2015) 0.76
Ischemic stroke detection system with a computer-aided diagnostic ability using an unsupervised feature perception enhancement method. Int J Biomed Imaging (2014) 0.76
Sepsis: a review for the neurohospitalist. Neurohospitalist (2012) 0.76
Pre-existing hypertension dominates γδT cell reduction in human ischemic stroke. PLoS One (2014) 0.76
Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke. Nat Commun (2015) 0.76
New Concept of Neural Stem Cell Transplantation: Anti-inflammatory Role. Int J Stem Cells (2008) 0.76
Rat middle cerebral artery occlusion is not a suitable model for the study of stroke-induced spontaneous infections. PLoS One (2014) 0.76
Early Diagnosis of Pneumonia in Severe Stroke: Clinical Features and the Diagnostic Role of C-Reactive Protein. PLoS One (2016) 0.76
Potential specific immunological indicators for stroke associated infection are partly modulated by sympathetic pathway activation. Oncotarget (2016) 0.75
Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration. Assay Drug Dev Technol (2016) 0.75
Sex-Related Differences in the Risk of Hospital-Acquired Sepsis and Pneumonia Post Acute Ischemic Stroke. J Stroke Cerebrovasc Dis (2016) 0.75
Leukoaraiosis is associated with pneumonia after acute ischemic stroke. BMC Neurol (2017) 0.75
A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression - A Pilot Study. Front Neurol (2016) 0.75
Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data. PLoS One (2015) 0.75
Urinary Tract Infections in Hospitalized Ischemic Stroke Patients: Source and Impact on Outcome. Cureus (2017) 0.75
The role of the immunoinflammatory response after cardiac arrest. Arch Med Sci (2011) 0.75
Is early clinical evidence of autonomic shift predictive of infection after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis (2013) 0.75
Risk of Acute Stroke After Hospitalization for Sepsis: A Case-Crossover Study. Stroke (2017) 0.75
Changes in the cellular immune system and circulating inflammatory markers of stroke patients. Oncotarget (2016) 0.75
Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging. Oncotarget (2016) 0.75
Effect of Inducible Co-Stimulatory Molecule siRNA in Cerebral Infarction Rat Models. Med Sci Monit (2015) 0.75
Prolonged Activation of Invariant Natural Killer T Cells and TH2-Skewed Immunity in Stroke Patients. Front Neurol (2017) 0.75
Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms. Pathog Glob Health (2015) 0.75
Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi. Circulation (2017) 0.75
Neutrophil-to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage. Oncotarget (2017) 0.75
Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study. Clin Proteomics (2017) 0.75
Circulating leukocytes perpetuate stroke-induced aortic dysfunction. Exp Physiol (2017) 0.75
Endotoxemia induces lung-brain coupling and multi-organ injury following cerebral ischemia-reperfusion. Exp Neurol (2017) 0.75
Flow Cytometric Characterization of T Cell Subsets and Microglia After Repetitive Mild Traumatic Brain Injury in Rats. Neurochem Res (2017) 0.75
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med (2003) 3.89
Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet (2010) 3.60
Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci (2005) 3.45
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol (2009) 2.98
Terminally differentiated CD8⁺ T cells negatively affect bone regeneration in humans. Sci Transl Med (2013) 2.43
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One (2008) 2.39
Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma. Eur J Endocrinol (2014) 2.13
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology (2012) 2.09
The immunology of acute stroke. Nat Rev Neurol (2012) 2.06
Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci (2002) 2.05
Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord (2012) 1.99
The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med (2004) 1.90
Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers. Pharmacogenetics (2002) 1.85
Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol (2007) 1.85
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study. Lancet Neurol (2013) 1.76
Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood (2003) 1.76
Controlled growth of tetrapod-branched inorganic nanocrystals. Nat Mater (2003) 1.76
Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem (2005) 1.74
Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke (2003) 1.65
Pathophysiology of stroke: lessons from animal models. Metab Brain Dis (2004) 1.61
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin Pharmacol Ther (2002) 1.58
Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun Rev (2007) 1.47
Autonomic function and cerebral autoregulation in patients undergoing carotid endarterectomy. Circ J (2010) 1.45
Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab (2002) 1.44
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis (2007) 1.42
Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol (2009) 1.42
Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers. Clin Pharmacol Ther (2002) 1.42
Local endothelial dysfunction does not affect global endothelial function. Vasa (2015) 1.39
Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke (2006) 1.39
Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest (2005) 1.32
Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning? Neuropharmacology (2008) 1.31
Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study. Transplant Res (2013) 1.27
TLR2 mediates neuroinflammation and neuronal damage. J Immunol (2007) 1.26
Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci (2013) 1.25
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS One (2010) 1.25
Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke. Stroke (2012) 1.22
Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J Neurosci (2002) 1.22
Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase. J Clin Invest (2004) 1.22
Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp Neurol (2007) 1.21
Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke (2003) 1.21
Isoflurane induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism? Neuroreport (2002) 1.20
Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus. Ann Rheum Dis (2012) 1.18
Thoracoscopic thymectomy with the da Vinci robotic system for myasthenia gravis. Ann N Y Acad Sci (2008) 1.17
Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care (2009) 1.16
Therapeutic decisions in multiple sclerosis: moving beyond efficacy. JAMA Neurol (2013) 1.16
Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation. Proc Natl Acad Sci U S A (2011) 1.15
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J Mol Med (Berl) (2008) 1.14
Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids. J Neurosci (2007) 1.12
Dual phases of apoptosis in pneumococcal meningitis. J Infect Dis (2004) 1.11
Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO. J Cereb Blood Flow Metab (2012) 1.11
Group B streptococcal beta-hemolysin induces mortality and liver injury in experimental sepsis. J Infect Dis (2002) 1.08
Immune responses after acute ischemic stroke or myocardial infarction. Int J Cardiol (2010) 1.08
Nocturnal blood pressure, 3-methoxy-4-hydroxyphenylglycol and carotid intima-media thickness: The SABPA study. Heart Lung Circ (2013) 1.08
Neuronal gelsolin prevents apoptosis by enhancing actin depolymerization. Mol Cell Neurosci (2004) 1.07
Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state. Proc Natl Acad Sci U S A (2012) 1.07
Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires. J Immunol (2005) 1.06
Decision-making in the diagnosis and treatment of stroke-associated pneumonia. J Neurol Neurosurg Psychiatry (2012) 1.05
Suppressing immunosuppression after stroke. N Engl J Med (2011) 1.05
Effects of the PDE5-inhibitor vardenafil in a mouse stroke model. Brain Res (2009) 1.03
Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors. Mult Scler (2013) 1.02
Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp Dermatol (2007) 1.02
Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord (2009) 1.02
Association between socioeconomic status and functional impairment 3 months after ischemic stroke: the Berlin Stroke Register. Stroke (2012) 1.02
Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets. Eur J Immunol (2010) 1.01
Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples. Transplantation (2009) 1.01
Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis (2011) 1.01
Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients. Arthritis Res Ther (2009) 1.01
MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males. Br J Clin Pharmacol (2002) 0.99
Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers. Clin Pharmacokinet (2004) 0.99
Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytometry B Clin Cytom (2003) 0.99
Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (2004) 0.99
CCN1: a novel inflammation-regulated biphasic immune cell migration modulator. Cell Mol Life Sci (2012) 0.98
Immunodepression after aneurysmal subarachnoid hemorrhage. Stroke (2010) 0.96
Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro and in vivo. J Neurosci (2003) 0.96
Different modes of IL-10 and TGF-beta to inhibit cytokine-dependent IFN-gamma production: consequences for reversal of lipopolysaccharide desensitization. J Immunol (2003) 0.95
Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: the SABPA study. J Hypertens (2012) 0.95
Gait analysis as a method for assessing neurological outcome in a mouse model of stroke. J Neurosci Methods (2012) 0.94
Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolites. Pharmacogenetics (2003) 0.94
Epigenetic mechanisms in cerebral ischemia. J Cereb Blood Flow Metab (2013) 0.93
Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis (2003) 0.93
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Ann Neurol (2010) 0.93
Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways. J Cell Sci (2011) 0.92
Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons. Neurotoxicology (2007) 0.92